Oversold

CRMD

Valuation47/ 100
Cash flow & growth93/ 100
Upside potential51/ 100
Risk potential38/ 100

CRMD's valuation appears fair while strong fundamentals support the investment case and weaker than expected earnings are holding it back, though analyst coverage is limited and estimates vary widely.

Score change since last week

The score fell 4 points, mainly due to valuation and price changes. Price rose 1.6%, from $8.30 to $8.43. Reported EPS was unchanged, so the higher price reduced valuation support.

Valuation and price changes subtracted 3.2 points. The comparison uses the same available inputs on both dates. Displayed changes are rounded to whole points.

Valuation

Historical cheapness: current PE is 4× versus the full-history median of 3.2× shown in the valuation table, producing 38.5/100. Positive weekly observations receive equal weight; lower past EPS alone does not disqualify them.

Outlook-adjusted valuation: 46.6/100. The model applies a 37.7% earnings-growth assumption and a 10% annual return hurdle, with positive credit limited by evidence coverage and confidence.

Forward price scenarios use recent PE history separately. Recent history has a separately weighted median of 3.4× (18-month half-life). The favorable scenario uses 3.5× PE and $3.2 projected EPS, informed by growth, margins and earnings-quality checks. This is a model scenario, not an analyst target. A return to the full-history median is not assumed.

Cash flow & growth

Business trends are strong. Over the past year: revenue +280.5%, earnings +182.9%, operating margin +6.4 percentage points. Free cash flow is 54.5% of revenue. The business score is 92.9/100. Growth, margins and cash generation drive the score. Missing or older data receives less weight.

Favorable scenario

Stronger earnings and valuation could support a higher share price.

Our favorable case uses $3.17 of EPS and a 3.5× PE, suggesting a share price of about $11.26. Valuation history and outlook inform the PE.

The displayed favorable scenario is 33.5% upside, or about $11.25.

This is a scenario based on our model, not a forecast or probability.

Downside scenario

Weaker than expected earnings could put pressure on the share price.

Our downside case uses $1.84 of EPS and a 2.8× PE, suggesting a share price of about $5.25 — 38% below today’s price. Valuation history and outlook inform the PE.

This is a scenario based on our model, not a forecast or probability.

CRMD vs Historical averages

MetricCurrentAverageRelative
PE4x8.7x54% lower
PE percentile715042% higher
EPS$2.13-$0.31$2.44 higher
FCF$251.7M-$3.9M+$255.6M
Loading historical comparisons…

CRMD’s earnings are above their historical averages, while its earnings multiple is lower.

CRMD Forward outlook

MetricOutlook
Forward valuation--
Forward earningsTurning negative
Forward revenueStrong decline
Forward profitabilityStrongly contracting
Analyst coverageLimited
Estimate dispersionWide

CRMD’s outlook is weakening, with weaker expected earnings weighing on the picture.

CRMD PE Valuation

Loading pe valuation table…

This table applies CRMD's historical price-to-earnings (PE) landmarks to current earnings. The implied prices are valuation scenarios, not price forecasts or targets.

CRMD Earnings Per Share

Loading earnings per share…

This chart tracks CRMD's trailing twelve-month diluted earnings per share, calculated from four consecutive reported quarters to reduce seasonal noise.

CRMD Quarterly Revenue

Loading quarterly revenue…

This chart tracks CRMD's quarterly revenue over time and shows how sales are changing from year to year.

CRMD Free Cash Flow

Loading free cash flow…

This chart tracks CRMD's free cash flow over time, showing whether the business is consistently generating cash after operating costs and capital spending.

CRMD Total Shares

Loading shares over time…

This chart tracks changes in CRMD's diluted share count. A rising count can dilute existing owners, while a falling count often reflects share repurchases.

CRMD Net Leverage

Loading net leverage…

Quarterly Net Leverage uses the last 12 months of EBITDA. A falling multiple generally indicates less debt relative to earnings capacity. Negative values mean net cash; missing data or nonpositive LTM EBITDA are N/A. The table shows each period’s Net Leverage and status.

CRMD PE vs Healthcare Sector

Loading pe vs sector average…

This chart compares CRMD's price-to-earnings (PE) ratio with the Healthcare sector average. A discount or premium can reflect differences in expected growth, profitability, or risk.

CRMD Weekly Price

Loading weekly price…

This chart uses CRMD's weekly closing prices to show the longer-term trend. The lower panes show weekly RSI and Stochastic momentum.

CRMD Weekly Moving Averages

Loading weekly moving averages…

This chart compares CRMD's 8, 20, 50, 100, and 200-week moving averages from 2020 onward. Shorter averages react faster to price changes, while longer averages show the broader trend.

CRMD Yearly ROI

Loading yearly ROI…

Each line starts at 0% using the year’s first dependable weekly close and tracks the return through December, or through the latest available week for the current year.